Pantoprazole IV (Protonix IV).
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000191:economics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017277:Drug Approval; D005252:Fees, Pharmaceutical; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D009853:Omeprazole / Q000031:analogs & derivatives; D000077402:Pantoprazole; D016032:Randomized Controlled Trials as Topic; D013454:Sulfoxides / Q000008:administration & dosage* / Q000191:economics / Q000627:therapeutic use; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles; D013454:Sulfoxides; D000077402:Pantoprazole; D009853:Omeprazole